Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Crysvita

Burosumab-Twza

Open in the dashboard

Part D claims

1,753

Prescriptions dispensed, refills included

Drug cost

$45,165,663

Paid at the pharmacy, in all

Prescribers

90

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,753 claims for Crysvita (burosumab-twza) from 90 prescribers, at a total drug cost of $45.2 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 36 states and territories
Part D claims for Crysvita by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
PA 10 197 $4,605,906
CA 7 144 $3,226,623
NY 5 99 $2,629,301
TX 6 92 $2,071,565
IN 3 87 $2,117,493
GA 3 70 $1,220,882
KY 3 70 $2,614,996
IL 3 69 $2,183,369
FL 4 66 $1,528,084
MN 3 60 $3,080,814
VA 3 56 $837,848
NC 3 55 $1,393,907
AZ 4 53 $1,744,110
TN 1 46 $993,691
AR 2 46 $1,467,863
The other 21 states and territories
State Prescribers Claims Drug cost
MO 1 45 $1,249,972
CO 3 44 $1,326,665
WI 2 40 $736,556
WA 3 38 $1,036,934
MD 3 38 $2,798,600
NV 1 32 $544,857
MS 2 30 $474,852
OH 2 29 $693,729
MA 1 28 $425,250
AK 1 26 $408,185
MI 1 26 $481,469
OR 1 24 $659,711
LA 1 24 $253,199
AL 1 24 $288,454
KS 1 23 $244,974
HI 1 16 $181,615
IA 1 12 $401,296
SC 1 11 $278,214
UT 1 11 $315,399
CT 1 11 $199,778
MT 1 11 $449,505

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 8 of 8
Part D claims for Crysvita by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Endocrinology 61 1,203 $32,031,866
Internal Medicine 12 214 $4,855,406
Nephrology 5 85 $2,531,381
Physician Assistant 4 70 $1,446,692
Nurse Practitioner 3 57 $1,404,301
Medical Genetics and Genomics 2 57 $1,747,974
Pediatric Medicine 2 39 $722,793
Rheumatology 1 28 $425,250

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 90 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Kathryn Dahir Endocrinology TN 46 $993,691 $9,013
Gary Gottesman Medical Genetics and Genomics MO 45 $1,249,972 $103
Erik Imel Endocrinology IN 38 $1,032,430 $15,280
Nicole Chan Internal Medicine NY 36 $897,667 None on record
Sumit Bhagra Endocrinology MN 34 $599,484 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 90 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record